The Journal of the American Medical Association has appointed prominent health-equity researcher Kirsten Bibbins-Domingo, MD, PhD, as the first person of color to serve as editor-in-chief.
Bibbins-Domingo is an epidemiologist and biostatistician at the University of California, San Francisco, School of Medicine. She also served there as the inaugural vice dean for population health and health equity and co-founded the UCSF Center for Vulnerable Populations at the Zuckerberg San Francisco General Hospital.
She will assume the position July 1, taking over for interim editor-in-chief Phil Fontanarosa, MD.
Health equity will be a primary focus for Bibbins-Domingo in her upcoming role, she said Monday during a media conference.
“The entire scientific and medical enterprise has been plagued by the inability to acknowledge these important forces that shape the health of our patients,” she said, “and we know that some of this blindness to seeing these forces has to do with who’s in the room making the decisions, who’s in the room conducting studies, who’s in the room shaping policy, who’s in the room deciding what gets published.”
“Doing the hard reflection on how we do what is best for science and the health of our patients is the important journey that we’re all on right now,” she said.
In March 2021, the American Medical Association’s Journal Oversight Committee announced that its then-top editor Howard Bauchner, MD, was placed on administrative leave.
The shakeup occurred when Edward H. Livingston, MD, who at the time was JAMA’s deputy editor, questioned the existence of structural racism while hosting a podcast.
“Structural racism is an unfortunate term,” he said in the podcast. “Personally, I think taking racism out of the conversation will help. Many of us are offended by the concept that we are racist.”
The audio was deleted from JAMA’s website, but the journal subsequently faced harsh criticisms about both the podcast and what many said were years of ignoring and enabling racism in medicine.
Bibbins-Domingo said the journal and the JAMA Network have made “several important changes as a result of that event,” including an increased focus on diversity among editors, reviewers, and authors to better “shape the type of content that appears” in the journal.
In addition to health equity, Bibbins-Domingo said she will work on combating some of the mistrust in medicine and science that has become evident during the COVID-19 pandemic.
“We are tremendously pleased and fortunate to welcome Dr Bibbins-Domingo as the new editor-in-chief where she will lead JAMA into a new era of publishing the groundbreaking research that is shaping the future of medicine and science,” said AMA Chief Executive Officer and Executive Vice President James L. Madara, MD, in a statement.
“As a physician, scholar, and leader, she has focused on health equity, on cardiovascular disease prevention — top priorities for the AMA — and more recently on COVID-19,” Madara said. “I am confident Dr Bibbins-Domingo — with her remarkable professional background ranging from basic science to an array of scholarly approaches to clinical studies — will effectively advance JAMA’s mission that accelerates clinical research into practice at this critical time in healthcare in the US and in global public health.”